Fig. 5
(A) The Western-blot analysis was conducted to assess the levels of SULT1E1 expression in 7 pairs of LUAD tissues and their corresponding normal tissues. This was done using grey value analysis, and the findings were illustrated through bar graphs. (B) The expression levels of SULT1E1 mRNA in lung adenocarcinoma tissues and normal tissues were detected by RT-qPCR and visualized as bar graphs. (C) Western-blot assay to determine the expression level of SULT1E1 in several human LUAD cell lines with grey value analysis, and the results were visualised using bar graphs. (D) IHC staining of tumour tissues and adjacent normal lung tissues in LUAD patients. (E) Kaplan-Meier survival analysis of LUAD patients with different SULT1E1 expression levels in immunohistochemistry. (F) Cellular immunofluorescence to determine the distribution of SILT1E1 expression in H1299, A549 cells. (T is lung adenocarcinoma tumour tissue, N is adjacent normal lung tissue, *: P < 0.05, **: P < 0.01, ***: P < 0.001).
